Harrow posts record Q3 revenue, cuts 2026 Adjusted EBITDA outlookNov 9Quarterly updatechloroprocaine hydrochloride ophthalmic gelHarrow Inc
Completed trial compares Iheezo to standard anesthesia for intravitreal injections, lists Harrow as Aug 21Trial updatechloroprocaine hydrochloride ophthalmic gelHarrow Inc
Harrow reports Q2 2026 results, reiterates full-year guidance, cites pipeline progressAug 10Quarterly updateHarrow Inc